Open AccessPioglitazone ameliorates retinal ischemia/reperfusion injury via suppressing NLRP3 inflammasome activities
Author(s) -
Yue-Lu Zhang,
Ruo-Bing Wang,
Weiyi Li,
Fangzhou Xia,
Lin Liu
Publication year - 2017
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2017.12.04
Subject(s) - medicine , pioglitazone , inflammasome , pharmacology , reperfusion injury , ischemia , retinal , cardioprotection , ophthalmology , cardiology , inflammation , diabetes mellitus , endocrinology , type 2 diabetes
To explore the role of Pioglitazone (Pio) on a mouse model of retinal ischemia/reperfusion (I/R) injury and to elucidate the potential mechanism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom